Cargando…

Liver Disease-Related Sarcopenia: A Predictor of Poor Prognosis by Accelerating Hepatic Decompensation in Advanced Chronic Liver Disease

Background Sarcopenia is considered a prognostic factor for advanced chronic liver disease (ACLD) independent of liver function, but the underlying mechanisms are unknown. Here, we investigated whether sarcopenia contributed to hepatic decompensation and worsened prognosis. Methods This was a single...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Atsushi, Yoshimura, Tsubasa, Ichikawa, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658123/ https://www.ncbi.nlm.nih.gov/pubmed/38024081 http://dx.doi.org/10.7759/cureus.49078

Ejemplares similares

Diagnosis and Pathogenesis of Sarcopenia in Chronic Liver Disease Using Liver Magnetic Resonance Imaging
por: Nakamura, Atsushi, et al.
Publicado: (2022)

Mildly Low Serum Sodium Levels in Chronic Liver Disease: At Risk for Sarcopenia and Portal Hypertension
por: Nakamura, Atsushi, et al.
Publicado: (2023)

A Case of Hepatitis C-Related Decompensated Cirrhosis Observed by MRI Imaging Data During Treatment With Direct-Acting Antiviral Agents
por: Nakamura, Atsushi, et al.
Publicado: (2021)

Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2018)

Treatment of Decompensated Alcoholic Liver Disease
por: Menachery, John, et al.
Publicado: (2011)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt
por: Praktiknjo, Michael, et al.
Publicado: (2019)

U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
por: Lin, Huapeng, et al.
Publicado: (2022)

Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
por: Iwaki, Michihiro, et al.
Publicado: (2023)

ADAM12 is an independent predictor of poor prognosis in liver cancer
por: Du, Shuangqiu, et al.
Publicado: (2022)

Erythropoietic protoporphyria: Delayed presentation with decompensated liver disease
por: Sarda, Radhika, et al.
Publicado: (2020)

Perspectives on Sarcopenia as a Predictor for Outcomes in Pediatric Patients with Chronic Liver Disease
por: Chen, Connie, et al.
Publicado: (2022)

Model for End Stage Liver Disease (MELD) Score: A Tool for Prognosis and Prediction of Mortality in Patients With Decompensated Liver Cirrhosis
por: Emenena, Isioma, et al.
Publicado: (2023)

Definition of Sarcopenia in Chronic Liver Disease
por: Son, Seong Wan, et al.
Publicado: (2021)

High plasma soluble thrombomodulin levels indicated poor prognosis of decompensated liver cirrhosis: a prospective cohort study
por: Wei, Xinhuan, et al.
Publicado: (2022)

Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients
por: Badran, Hanaa, et al.
Publicado: (2020)

Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease
por: Scheiner, Bernhard, et al.
Publicado: (2018)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
por: Shuai, Yu, et al.
Publicado: (2021)

Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease
por: Punamiya, Sundeep J., et al.
Publicado: (2011)

Spontaneous expulsive suprachoroidal hemorrhage caused by decompensated liver disease
por: Srikanth, Krishnagopal, et al.
Publicado: (2013)

Effect of COVID-19 on presentations of decompensated liver disease in Scotland
por: Manship, Thomas, et al.
Publicado: (2022)

Fucosylated Glycoproteins as Markers of Liver Disease
por: Mehta, Anand, et al.
Publicado: (2008)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Radiologic Definition of Sarcopenia in Chronic Liver Disease
por: Lee, Chul-min, et al.
Publicado: (2021)

Editorial: Sarcopenia, Frailty and Nutrition in Liver Diseases
por: Iacob, Speranta, et al.
Publicado: (2022)

Sarcopenia in children and adolescents with chronic liver disease()()
por: Rezende, Ionar Figueredo Bonfim, et al.
Publicado: (2019)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Daclatasvir and sofosbuvir treatment of decompensated liver disease or post‐liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real‐world cohort
por: Kwo, Paul, et al.
Publicado: (2018)

A potential novel inflammation biomarker for predicting the prognosis of decompensated liver cirrhosis
por: Xie, Yanan, et al.
Publicado: (2022)

Management of Liver Decompensation in Advanced Liver Disease (Renal Impairment, Liver Failure, Adrenal Insufficiency, Cardiopulmonary Complications)
por: Téllez, Luis, et al.
Publicado: (2022)

Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding
por: Baiges, Anna, et al.
Publicado: (2022)

High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer
por: Meng, Jiyu, et al.
Publicado: (2023)

Hypocoagulability in Children With Decompensated Chronic Liver Disease and Sepsis: Assessment by Thromboelastography
por: Vinayagamoorthy, Vignesh, et al.
Publicado: (2023)

Hepatic Encephalopathy Confirmed by Magnetic Resonance Imaging in a Patient with Unobvious Cause of Chronic Liver Disease Decompensation
por: Czempik, Piotr F., et al.
Publicado: (2023)

Predictors of hepatic decompensation after TACE for hepatocellular carcinoma
por: Kohla, Mohamed A S, et al.
Publicado: (2015)

Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis
por: Lee, Woo Jin, et al.
Publicado: (2011)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2011)

Concentrations of Connective Tissue Growth Factor in Patients with Nonalcoholic Fatty Liver Disease: Association with Liver Fibrosis
por: Colak, Yasar, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_920p7rgbkafm9een0cbdjg3hun